About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 108 record(s)
Req # A-2022-000376
Adverse Drug Reactions (ADRs). Report numbers: E2B_05027306, E2B_05027749, E2B_05041525, E2B_05041676, E2B_05041681, E2B_05045955, E2B_05045991, E2B_05046000, E2B_05046388, E2B_05046993.Organization: Health Canada
September 2022
Req # A-2022-000378
Adverse Drug Reactions (ADRs) for Isentress. Report numbers: E2B_03193230, E2B 03162032, E2B_03427393, E2B_03175543, E2B_03167269, E2B_03073540, E2B_02260351, E2B_02979508, E2B_03070843.Organization: Health Canada
September 2022
Req # A-2022-000387
Adverse Drug Reactions (ADRs). Report numbers: E2B_04613773, E2B_04695602, E2B_04802064, E2B_03468353.Organization: Health Canada
September 2022
Req # A-2022-000400
Adverse Drug Reactions (ADRs). Report numbers: 000937668, 000959614, 000979804, E2B_05013610, E2B_04972078, E2B_05069161.Organization: Health Canada
September 2022
Req # A-2022-000405
Adverse Drug Reactions (ADRs) for Morphine. Report numbers: E2B_05155246, E2B_05168402, E2B_05189995, 000985350, 000987930, E2B_05269774. ADRs for Hydromorphone. Report numbers: 000985350, E2B_02972100, 000988826. ADR for Midazolam. Report number: 000989868.Organization: Health Canada
September 2022
Req # A-2022-000416
Adverse Drug Reactions (ADRs). Report numbers: E2B_04935461, 000988597, E2B_05282371.Organization: Health Canada
September 2022
Req # A-2022-000418
Adverse Drug Reactions (ADRs). Report numbers: E2B_05292855, 000975612, 000972417, E2B_05028169, E2B_05266157.Organization: Health Canada
September 2022
Req # A-2022-000444
Adverse Drug Reactions (ADRs) for . Report numbers: E2B_02979492, E2B_02979532, E2B_02983778, E2B_03073550, E2B_03073575, E2B_03073581, E2B_03009198, E2B_02983814.Organization: Health Canada
September 2022
Req # A-2022-000491
Adverse Drug Reactions (ADRs). Report numbers: 000988654, 000983711, E2B_04733661.Organization: Health Canada
September 2022
Req # A-2022-000497
Adverse Drug Reactions (ADRs) for CIPRALEX. Report numbers: 967863, E2B_04630340.Organization: Health Canada
September 2022